§ 1728c - Use of oral therapeutic pharmaceutical agent; communication with primary care provider - Vermont Statutes

§ 1728c. Use of oral therapeutic pharmaceutical agent; communication with primary care provider

A licensee who employs an oral therapeutic pharmaceutical agent, as identified by the formulary established in section 1724a of this title, which might prove to have significant systemic adverse reactions or systemic side effects shall, in a manner consistent with Vermont law, ascertain the risk of systemic side effects through either a case history or by communicating with the patient's primary care provider. The licensee shall also communicate with the patient's primary care provider, or with a physician skilled in diseases of the eye, when in the professional judgment of the licensee, it is medically appropriate. The communication shall be noted in the patient's permanent record. The methodology of communication shall be determined by the licensee. (Added 2003, No. 108 (Adj. Sess.), § 8; amended 2005, No. 148 (Adj. Sess.), § 16.)